Strategies for a Multidisciplinary Approach to Anticoagulation Management with VTE
This video is part of a larger CE/CME Certified program entitled: Preventing and Treating Clots: Anticoagulation and Venous Thromboembolism. You can receive free CME credit, view this video, and download slides from the presentation at https://www.mededonthego.com/Video/program/1119
Видео Strategies for a Multidisciplinary Approach to Anticoagulation Management with VTE канала MedEdOTG
Видео Strategies for a Multidisciplinary Approach to Anticoagulation Management with VTE канала MedEdOTG
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
How the Presence of PoPH, With or Without Treatment, Impacts Patients Who Need A Liver Transplant
Should I Use Checkpoint Inhibitors in Advanced NSCLC with Targetable Molecular Alterations?
Treatment Free Remission and Nilotinib
Emerging Agents and Combinations to Treat RET Fusion-Positive Lung Cancers
Panel Discussion: Challenges and Opportunities to Managing EGFR Exon 20 Mutations
Optimizing ED Triage Strategies for Agitated BD & SCZ Patients
Improving Patient Outcomes: Beneficial & Adverse Effect Profiles of SCZ Antipsychotic Agents
Novel DMTs for Mild Cognitive Impairment Due to AD: Efficacy & Safety of New DMTs for MCI
AML Risk Stratification: Cytogenetics and Mutational Analysis - Part 1
Thinking Out of the Box: Monotherapies versus Adjunctive Therapies in Bipolar I and II Depression
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
Moving Beyond Cytotoxic Chemotherapy: Tagraxofusp-erzs
Single or Dual Agent IO/Chemotherapy for PD-L1 Negative NSCLC
Case: Aunt Judy Has Been Hallucinating - Treatment Interventions for Parkinson’s Disease Psychosis
You are not alone! Patient Advocacy and Organizations
Pediatric BPDCN and Use of Tagraxofusp in Children
JAK Inhibition in SR cGVHD: REACH 3, GRAVITAS-309
Nivolumab + Ipilimumab + 2 Cycles of Platinum-doublet Chemo vs 4 Cycles Chemo for Stage IV NSCLC
Which Combination Therapy Do I Choose for Frontline Treatment of MPM?
Bleeds with Vitamin K Antagonist Managed in the ED or ICU
Selecting and Managing RET-Targeted Therapy in mNSCLC